Published in Clin Infect Dis on May 01, 1998
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol (2004) 4.03
Identification of Aspergillus species using internal transcribed spacer regions 1 and 2. J Clin Microbiol (2000) 3.41
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol (2003) 2.89
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol (1999) 2.82
Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. Antimicrob Agents Chemother (2001) 2.68
Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol (1999) 2.02
Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). J Clin Microbiol (2003) 1.89
Aspergillus species identification in the clinical setting. Stud Mycol (2007) 1.81
Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol (2001) 1.54
E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol (2002) 1.51
In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection. Antimicrob Agents Chemother (2004) 1.44
In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp. Antimicrob Agents Chemother (2003) 1.40
Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol (2002) 1.40
Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis (2006) 1.35
Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol (2003) 1.31
Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation. J Clin Microbiol (1998) 1.28
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother (2008) 1.11
Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus. J Clin Microbiol (2000) 1.01
Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia. J Clin Microbiol (2000) 1.01
Aspergillus alabamensis, a new clinically relevant species in the section Terrei. Eukaryot Cell (2009) 1.00
Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay. J Clin Microbiol (2004) 0.98
Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol (2007) 0.96
Aspergillus terreus accessory conidia are unique in surface architecture, cell wall composition and germination kinetics. PLoS One (2009) 0.96
New species in Aspergillus section Terrei. Stud Mycol (2011) 0.95
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients. Infect Drug Resist (2012) 0.93
Antifungal therapy of murine Aspergillus terreus infection. Antimicrob Agents Chemother (2004) 0.91
Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus. J Clin Microbiol (2003) 0.89
In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus. Antimicrob Agents Chemother (2005) 0.86
Overcoming antifungal resistance. Drug Discov Today Technol (2014) 0.85
Dissimilatory nitrate reduction by Aspergillus terreus isolated from the seasonal oxygen minimum zone in the Arabian Sea. BMC Microbiol (2014) 0.84
Efficacy of caspofungin against Aspergillus terreus. Antimicrob Agents Chemother (2005) 0.83
Monoclonal antibodies to hyphal exoantigens derived from the opportunistic pathogen Aspergillus terreus. Clin Vaccine Immunol (2011) 0.80
Development of monoclonal antibodies to recombinant terrelysin and characterization of expression in Aspergillus terreus. J Med Microbiol (2011) 0.78
Ceftriaxone-resistant salmonella infection acquired by a child from cattle. N Engl J Med (2000) 4.68
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura. Lancet (1997) 4.09
The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science (1987) 4.01
Identification of Aspergillus species using internal transcribed spacer regions 1 and 2. J Clin Microbiol (2000) 3.41
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 3.33
Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol (2002) 3.14
The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature (1988) 3.07
AIDS serology testing in low- and high-risk groups. JAMA (1985) 2.74
Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob Agents Chemother (2002) 2.69
Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis (2000) 2.08
A transgenic mouse model for human neurofibromatosis. Science (1987) 2.05
Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature (1989) 1.98
Optimal therapy for patients with biliary atresia: portoenterostomy ("Kasai" procedures) versus primary transplantation. J Pediatr Surg (1990) 1.86
Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med (1988) 1.77
Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol (1993) 1.69
Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol (1993) 1.66
Diagnosis and treatment of biliary tract complications after orthotopic liver transplantation. Surgery (1989) 1.66
99mTc-labeled divalent and tetravalent CC49 single-chain Fv's: novel imaging agents for rapid in vivo localization of human colon carcinoma. J Nucl Med (2001) 1.59
High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol (1993) 1.58
Short-bowel syndrome in children and adults. Gastroenterology (1997) 1.54
Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology (1994) 1.54
Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect Immun (1999) 1.51
Proton spectroscopy of brain glutamine in acute liver failure. Hepatology (1995) 1.49
Clonality in nodular lymphocyte-predominant Hodgkin's disease. N Engl J Med (1997) 1.46
Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem (2000) 1.44
A percutaneous method for venovenous bypass in liver transplantation. Transplantation (1994) 1.44
Correlation of mucosal disaccharidase activities with histology in evaluation of rejection following intestinal transplantation. Pediatr Transplant (1998) 1.41
Incidence, risk factors, and outcomes associated with cytomegalovirus disease in small bowel transplant recipients. Pediatr Transplant (2011) 1.39
Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol (2007) 1.39
Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob Agents Chemother (1997) 1.37
Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis (1997) 1.36
Stratifying the causes of death in liver transplant recipients. An approach to improving survival. Arch Surg (1989) 1.33
Surgical complications in solitary pancreas and combined pancreas-kidney transplantations. Am J Surg (1992) 1.33
Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant (2001) 1.32
Invasive infection due to Candida krusei in immunocompromised patients not treated with fluconazole. Clin Infect Dis (1995) 1.30
Genome diversity among regional populations of Francisella tularensis subspecies tularensis and Francisella tularensis subspecies holarctica isolated from the US. FEMS Microbiol Lett (2004) 1.29
Disseminated aspergillosis caused by Aspergillus ustus in a patient following allogeneic peripheral stem cell transplantation. J Clin Microbiol (1998) 1.28
Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg (1991) 1.27
Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. Am J Transplant (2006) 1.26
Genetic and phenotypic analysis of biofilm phenotypic variation in multiple Staphylococcus epidermidis isolates. J Med Microbiol (2004) 1.25
Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies. J Clin Microbiol (1987) 1.24
NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park) (2000) 1.22
Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens. J Clin Microbiol (1995) 1.21
Revised approach for identification and detection of ampicillin and vancomycin resistance in Enterococcus species by using MicroScan panels. J Clin Microbiol (1996) 1.20
SigmaB and SarA independently regulate polysaccharide intercellular adhesin production in Staphylococcus epidermidis. Can J Microbiol (2007) 1.19
The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints. Med Microbiol Immunol (2001) 1.19
Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. J Infect Dis (1991) 1.18
Surgical approach to short-bowel syndrome. Experience in a population of 160 patients. Ann Surg (1995) 1.17
Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther (2000) 1.14
Discordance between tuberculin skin test results with two commercial purified protein derivative preparations. J Infect Dis (1994) 1.13
Rapid diagnosis of invasive cytomegalovirus infection by examination of tissue specimens in centrifugation culture. Am J Clin Pathol (1987) 1.12
Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia. Am J Med (1993) 1.12
Characterization of the relationship between polysaccharide intercellular adhesin and hemagglutination in Staphylococcus epidermidis. J Infect Dis (1999) 1.11
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol (1994) 1.10
Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg (1989) 1.10
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant (1998) 1.10
Frozen section evaluation of donor livers before transplantation. Transplantation (1993) 1.10
Folate deficiency alone does not produce neural tube defects in mice. J Nutr (1992) 1.09
Routine sampling of air for fungi does not predict risk of invasive aspergillosis in immunocompromised patients. J Hosp Infect (2008) 1.08
Adherence of Staphylococcus epidermidis to biomaterials is augmented by PIA. Clin Orthop Relat Res (2006) 1.08
Causes of late mortality in pediatric liver transplant recipients. Ann Surg (1998) 1.08
Molecular diagnostics for the detection of musculoskeletal infection. Clin Orthop Relat Res (1999) 1.05
Evaluation of commercial AIDS screening test kits. Lancet (1985) 1.04
Transgenic mouse model for human gastric carcinoma. Proc Natl Acad Sci U S A (1989) 1.04
Multiple endocrine neoplasia induced by the promiscuous expression of a viral oncogene. Proc Natl Acad Sci U S A (1988) 1.02
Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol (1994) 1.02
Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol (1999) 1.01
Pulmonary infection caused by Gymnascella hyalinospora in a patient with acute myelogenous leukemia. J Clin Microbiol (2000) 1.01
Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty. Clin Orthop Relat Res (1999) 0.99
Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment. Oncogene (2000) 0.98
Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation (2000) 0.98
Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg (1992) 0.97
Bacteremia due to motile Enterococcus species: clinical features and outcomes. Clin Infect Dis (1999) 0.97
Molecular analysis of Francisella tularensis subspecies tularensis and holarctica. Am J Clin Pathol (2007) 0.97
Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22. Cancer Genet Cytogenet (1985) 0.97
Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastoma. J Virol (1990) 0.97
The presence of icaADBC is detrimental to the colonization of human skin by Staphylococcus epidermidis. Appl Environ Microbiol (2008) 0.97
Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg (1995) 0.96
Liver cancer in transgenic mice carrying the human immunodeficiency virus tat gene. Cancer Res (1991) 0.96
Environmental contamination with vancomycin-resistant enterococci in an outpatient setting. Infect Control Hosp Epidemiol (1998) 0.94
Klebsiella pneumoniae urinary tract infection complicated by endophthalmitis, perinephric abscess, and ecthyma gangrenosum. South Med J (1991) 0.94
Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci (1992) 0.93
Model of Staphylococcus aureus central venous catheter-associated infection in rats. Lab Anim Sci (1999) 0.92